Company Profile
Public information reviewedAardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, concentrating on developing small-molecule treatments.
USNASDAQ: AARD
Follow
More
- Evidence records
- 2
- Published leadership records
- 6
- Record reviewed
- Sep 25, 2026

